Abiopharma

Clinical trial NCT05217446 updates: 1. primary completion date: 2026-06-01 → 2026-06-19 2. enrollment: 107 → 108 participants

Clinical trial NCT06532032: primary completion date: 2026-04-14 → 2026-05-14.

Clinical trial NCT01804686: completion date: 2030-12-31 → 2029-12-31.

Clinical trial NCT06768489: completion date: 2029-01-02 → 2029-01-29.

Clinical trial NCT07387471 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 14 → 16 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06052631 updates: 1. status: RECRUITING → NOT_YET_RECRUITING 2. start date: 2026-08-04 → 2026-08-05

Clinical trial NCT06901531 updates: 1. completion date: 2028-09-30 → 2027-03-31 2. primary completion date: 2028-09-30 → 2027-03-31

Clinical trial NCT07669077: start date: 2026-06-26 → 2026-06-23.

Clinical trial NCT05488314: primary completion date: 2026-06-09 → 2027-04-28.

Clinical trial NCT05045820 updates: 1. completion date: 2026-06-20 → 2026-08-20 2. enrollment: 60 → 106 participants 3. enrollment type: ESTIMATED → ACTUAL